We're sorry, but this page has no content yet.
Medical Device Lawsuit Alerts
- OptraHealth, Inc. v. Invitae Corporation (New Lawsuit Alert)
- Decapolis Systems, LLC v. UT Southwestern Health Systems et al. (New Lawsuit Alert)
- Dental Monitoring v. Get-Grin Inc. (New Lawsuit Alert)
- Desert Harvest, Inc. v. Plus EV Holdings, Inc. d/b/a Intimate Rose (New Lawsuit Alert)
- Natera, Inc. f/k/a Gene Security Network v. CareDx, Inc. (New Lawsuit Alert)
Recent Medical Device News
- Siemens to acquire Varian for $16.4 Billion
- Presidio Medical Announces $30 Million Financing Round Led by Invus Opportunities
- Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies
- CVRx Raises $50 Million in New Equity Financing
- Medtronic Makes Offer for Medical Device Maker Intersect
U.S. FDA Approves Monkeypox Treatment Formulation
By Mark RubinshteinBy Mark Rubinshtein (May 25, 2022) SIGA Technologies Inc., a New York-based pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for an intravenous formulation of TPOXX (tecovirimat) for the treatment of smallpox. The U.S., Canada, and Europe have approved an oral formulation for treating smallpox, and Europe has also approved it for treating monkeypox and cowpox. The newly approved intravenous formulation provides an option for patients who are unable to swallow. The approval is welcome news as over 100 cases of monkeypox have been identifie...
Share